These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10381499)

  • 1. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus.
    Aiuti A; Turchetto L; Cota M; Cipponi A; Brambilla A; Arcelloni C; Paroni R; Vicenzi E; Bordignon C; Poli G
    Blood; 1999 Jul; 94(1):62-73. PubMed ID: 10381499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
    Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
    Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
    Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
    J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
    Möhle R; Bautz F; Rafii S; Moore MA; Brugger W; Kanz L
    Blood; 1998 Jun; 91(12):4523-30. PubMed ID: 9616148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.
    Lee B; Ratajczak J; Doms RW; Gewirtz AM; Ratajczak MZ
    Blood; 1999 Feb; 93(4):1145-56. PubMed ID: 9949156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
    Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
    Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
    J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
    Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
    Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets.
    Kowalska MA; Ratajczak J; Hoxie J; Brass LF; Gewirtz A; Poncz M; Ratajczak MZ
    Br J Haematol; 1999 Feb; 104(2):220-9. PubMed ID: 10050701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.
    Valenzuela-Fernández A; Palanche T; Amara A; Magerus A; Altmeyer R; Delaunay T; Virelizier JL; Baleux F; Galzi JL; Arenzana-Seisdedos F
    J Biol Chem; 2001 Jul; 276(28):26550-8. PubMed ID: 11352904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors.
    Aiuti A; Tavian M; Cipponi A; Ficara F; Zappone E; Hoxie J; Peault B; Bordignon C
    Eur J Immunol; 1999 Jun; 29(6):1823-31. PubMed ID: 10382744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states.
    Di Salvo J; Koch GE; Johnson KE; Blake AD; Daugherty BL; DeMartino JA; Sirotina-Meisher A; Liu Y; Springer MS; Cascieri MA; Sullivan KA
    Eur J Pharmacol; 2000 Dec; 409(2):143-54. PubMed ID: 11104827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV.
    Ruiz ME; Cicala C; Arthos J; Kinter A; Catanzaro AT; Adelsberger J; Holmes KL; Cohen OJ; Fauci AS
    J Immunol; 1998 Oct; 161(8):4169-76. PubMed ID: 9780190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.
    Majka M; Rozmyslowicz T; Lee B; Murphy SL; Pietrzkowski Z; Gaulton GN; Silberstein L; Ratajczak MZ
    J Clin Invest; 1999 Dec; 104(12):1739-49. PubMed ID: 10606628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles.
    Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A
    Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.